London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ovb 4p buy coming?
Up again and still zero interest on the forums
Then OVB are going to muscle in on a big and growing market with not that much successful competition. It could be like the the female viagra. Market and share price is not reflecting the gamble, valuation is tiny considering. I think a big spike will happen on anticipation of good results but you might be able to play safe and trade some too.
https://www.einnews.com/pr_news/588306896/hypoactive-sexual-desire-disorder-hsdd-treatment-market-in-latam-women-to-reach-170-million-by-2027-cagr-of-3-8
That have the fewer posts on the forums. Last post here was 30th July so 10 weeks without a peep and price has certainly tanked on little selling volumes so it could bounce back strongly considering what is happening atm.
How did this not go crazy on Fridays news? Female Viagra, phase 2 studies, large participant cohort. This could be multi billion dollar news in Q1 2023. Crazy
Interesting buying action so far today on this pretty illiquid stock, wonder if news coming soon? ……btw, despite showing as a sell the latest 25k trade @ 8.46am (12p) is a buy.
The licensing deal for Russia must be imminent as per the Rns. Not much stock about as keeps going NT.
I said one bag at 20p 9 more to go before war kicked of. I still maintain folk do not realise what these guys have...
Now a licence in theus would be nice:)
Few 100k buys just appeared. Great opportunity to be in early.
If you got in here. Back to 20p +...
If Russia/Ukraine agree a peace deal shortly as the media is intimating. Sentiment would soon turn. Already signs of the early birds getting on board with other Russia linked stocks such as EUA, POG, POLY….Not arrived here yet but likely will come soon. Would take much less of buying pressure to get this one to run higher.
Very harsh. The market cap is almost less than the cash OVB has (in safe jurisdictions at that). And, as has long been the case, no value is being ascribed to orenetide. On the flip side, this means - theoretically - the market cap shouldn't be falling below the value of the cash/equivalents, but over the last week we have seen it clearly has done just that. Glad today's price has taken us back to a slightly more reasonable place
So we $9.5 million in cash and cash equivalents held in UK, Irish and Australian banks. We only hold 125000 shares in Poly.
After that clarification from the company, I feel OVB has been harshly marked down because of the poly share price. Most our cash is in banks in safe jurisdictions.
Yes indeed. Particularly appreciated the excellent cash position information which highlighted that adverse exposure to the big drop in Polymetal SP has been relatively small (it would appear they had previously sold off most of their holding in POLY before its recent big drop in SP due to Ukraine situation). Will sit on my holding and wait for further news in due course.
Welcome RNS from the board, provides some comfort and clarity. Hopefully the price firms up a bit more from here.
In the interim results in Sept 2021 the company said more than 50% of patients had been enrolled in the phase 2 trial. I think it is therefore reasonable to assume that we should get an Rns in March confirming the dosing of the last patient in the trial. With already having completed 3 trials in Russia and gaining approval, the phase 2 trials should meet the end points.
I am hoping that we will then sign a licensing deal with a pharma to fund the phase 3 trials for USA and Europe.
Just wondered why the SP had plummeted so much after seemingly fantastic news. Any ideas? RUssia?
One bag yesterday, 9 more to go...
Seems like a decent entry point. The SP went high 20s in the last couple of years even without the authorisation - interesting to see what it does if OVB starts announcing any commercial partnerships
I’ve been adding on this dip as missed a decent entry yesterday.
This is surely worth ten times our present value. It will come in time.
At a Mcap of £18M surely OVB must be a sitting duck for a takeover target. We have approval in Russia on the back of data from 3 trials. We have a phase 2 trial nearing completion, which will have a very high chance of meeting the end points. Then all we need is one phase 3 trial to gain approval for USA and rest of the world. OVB is ridiculously undervalued and hence very appealing to other companies.